Tata Chemicals Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
Tata Chemicals wird ein jährliches Gewinn- und Umsatzwachstum von 68.4% bzw. 7.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 66.7% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 5% betragen.
Wichtige Informationen
68.4%
Wachstumsrate der Gewinne
66.7%
EPS-Wachstumsrate
Chemicals Gewinnwachstum | 22.9% |
Wachstumsrate der Einnahmen | 7.6% |
Zukünftige Eigenkapitalrendite | 5.0% |
Analystenabdeckung | Good |
Zuletzt aktualisiert | 04 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Tata Chemicals (NSE:TATACHEM) Will Be Hoping To Turn Its Returns On Capital Around
Oct 14Is Tata Chemicals (NSE:TATACHEM) Using Too Much Debt?
Sep 18What Tata Chemicals Limited's (NSE:TATACHEM) P/S Is Not Telling You
Jul 12Increases to CEO Compensation Might Be Put On Hold For Now at Tata Chemicals Limited (NSE:TATACHEM)
Jun 20Tata Chemicals (NSE:TATACHEM) Will Pay A Smaller Dividend Than Last Year
Jun 05Tata Chemicals' (NSE:TATACHEM) Dividend Will Be Reduced To ₹15.00
May 22Some May Be Optimistic About Tata Chemicals' (NSE:TATACHEM) Earnings
May 07Should You Investigate Tata Chemicals Limited (NSE:TATACHEM) At ₹1,102?
Apr 16Improved Earnings Required Before Tata Chemicals Limited (NSE:TATACHEM) Stock's 33% Jump Looks Justified
Mar 08Tata Chemicals Limited Just Missed EPS By 31%: Here's What Analysts Think Will Happen Next
Feb 08Here's Why Tata Chemicals (NSE:TATACHEM) Can Manage Its Debt Responsibly
Jan 19Earnings Working Against Tata Chemicals Limited's (NSE:TATACHEM) Share Price
Dec 27Here's Why Tata Chemicals (NSE:TATACHEM) Can Manage Its Debt Responsibly
Sep 29Is Tata Chemicals Limited (NSE:TATACHEM) Potentially Undervalued?
Sep 08Tata Chemicals (NSE:TATACHEM) Is Increasing Its Dividend To ₹17.50
Jun 02Tata Chemicals (NSE:TATACHEM) Is Increasing Its Dividend To ₹17.50
May 19What Is Tata Chemicals Limited's (NSE:TATACHEM) Share Price Doing?
May 05At ₹955, Is Tata Chemicals Limited (NSE:TATACHEM) Worth Looking At Closely?
Jan 31Is Tata Chemicals (NSE:TATACHEM) A Risky Investment?
Dec 26Is Now The Time To Look At Buying Tata Chemicals Limited (NSE:TATACHEM)?
Sep 20We Think Tata Chemicals (NSE:TATACHEM) Can Stay On Top Of Its Debt
Aug 31Tata Chemicals' (NSE:TATACHEM) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 10Tata Chemicals (NSE:TATACHEM) Is Increasing Its Dividend To ₹12.50
May 17Tata Chemicals' (NSE:TATACHEM) Upcoming Dividend Will Be Larger Than Last Year's
May 03Tata Chemicals (NSE:TATACHEM) Has A Pretty Healthy Balance Sheet
Mar 03Is Tata Chemicals Limited (NSE:TATACHEM) Worth ₹915 Based On Its Intrinsic Value?
Feb 12Why Tata Chemicals Limited (NSE:TATACHEM) Could Be Worth Watching
Jan 26We Think Tata Chemicals (NSE:TATACHEM) Can Stay On Top Of Its Debt
Nov 23A Look At The Intrinsic Value Of Tata Chemicals Limited (NSE:TATACHEM)
Nov 04Is It Too Late To Consider Buying Tata Chemicals Limited (NSE:TATACHEM)?
Oct 18Is Tata Chemicals (NSE:TATACHEM) A Risky Investment?
Aug 03At ₹781, Is It Time To Put Tata Chemicals Limited (NSE:TATACHEM) On Your Watch List?
Jul 16Most Shareholders Will Probably Agree With Tata Chemicals Limited's (NSE:TATACHEM) CEO Compensation
Jun 25Is Tata Chemicals (NSE:TATACHEM) Using Too Much Debt?
Mar 24Tata Chemicals Limited's (NSE:TATACHEM) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Mar 08Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
3/31/2027 | 180,367 | 13,465 | 12,917 | 25,360 | 7 |
3/31/2026 | 166,338 | 11,487 | 12,205 | 22,898 | 8 |
3/31/2025 | 153,339 | 7,766 | 5,132 | 17,871 | 7 |
9/30/2024 | 149,930 | -3,400 | 2,300 | 21,960 | N/A |
6/30/2024 | 149,920 | -1,060 | N/A | N/A | N/A |
3/31/2024 | 154,210 | 2,820 | 11,820 | 30,160 | N/A |
12/31/2023 | 163,530 | 18,200 | N/A | N/A | N/A |
9/30/2023 | 167,710 | 20,600 | 15,820 | 32,430 | N/A |
6/30/2023 | 170,120 | 22,650 | N/A | N/A | N/A |
3/31/2023 | 167,890 | 23,350 | 13,930 | 29,710 | N/A |
12/31/2022 | 158,631 | 20,866 | N/A | N/A | N/A |
9/30/2022 | 148,561 | 19,896 | 7,255 | 21,643 | N/A |
6/30/2022 | 136,391 | 15,576 | N/A | N/A | N/A |
3/31/2022 | 126,220 | 12,530 | 3,680 | 16,450 | N/A |
12/31/2021 | 117,777 | 8,014 | N/A | N/A | N/A |
9/30/2021 | 112,422 | 6,613 | 1,200 | 13,576 | N/A |
6/30/2021 | 108,289 | 5,311 | N/A | N/A | N/A |
3/31/2021 | 101,998 | 2,564 | 7,954 | 20,373 | N/A |
12/31/2020 | 99,417 | 4,293 | N/A | N/A | N/A |
9/30/2020 | 99,590 | 4,355 | 8,305 | 20,129 | N/A |
6/30/2020 | 101,209 | 6,620 | N/A | N/A | N/A |
3/31/2020 | 103,568 | 8,066 | 5,807 | 17,801 | N/A |
12/31/2019 | 114,887 | 11,995 | N/A | N/A | N/A |
9/30/2019 | 115,717 | 11,916 | 7,012 | 19,734 | N/A |
6/30/2019 | 114,489 | 11,585 | N/A | N/A | N/A |
3/31/2019 | 103,367 | 9,319 | 5,000 | 15,823 | N/A |
12/31/2018 | 110,920 | 10,695 | N/A | N/A | N/A |
9/30/2018 | 108,328 | 13,955 | N/A | N/A | N/A |
6/30/2018 | 105,871 | 13,319 | N/A | N/A | N/A |
3/31/2018 | 102,697 | 12,906 | N/A | 18,692 | N/A |
12/31/2017 | 128,262 | 12,110 | N/A | N/A | N/A |
9/30/2017 | 123,813 | 8,930 | N/A | N/A | N/A |
6/30/2017 | 122,988 | 7,999 | N/A | N/A | N/A |
3/31/2017 | 103,461 | 8,796 | N/A | 35,308 | N/A |
12/31/2016 | 163,372 | 8,854 | N/A | N/A | N/A |
9/30/2016 | 168,402 | 8,292 | N/A | N/A | N/A |
6/30/2016 | 173,604 | 8,388 | N/A | N/A | N/A |
3/31/2016 | 148,729 | 6,964 | N/A | 23,319 | N/A |
12/31/2015 | 174,436 | 4,638 | N/A | N/A | N/A |
9/30/2015 | 176,230 | 5,719 | N/A | N/A | N/A |
6/30/2015 | 174,196 | 5,740 | N/A | N/A | N/A |
3/31/2015 | 172,045 | 5,965 | N/A | 12,736 | N/A |
12/31/2014 | 170,708 | -5,551 | N/A | N/A | N/A |
9/30/2014 | 169,026 | -8,091 | N/A | N/A | N/A |
6/30/2014 | 164,427 | -9,317 | N/A | N/A | N/A |
3/31/2014 | 158,854 | -10,320 | N/A | 23,376 | N/A |
12/31/2013 | 156,739 | 57 | N/A | N/A | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: TATACHEM wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (6.7%).
Ertrag vs. Markt: TATACHEM wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.
Hohe Wachstumserträge: TATACHEM wird voraussichtlich in den nächsten 3 Jahren rentabel werden.
Einnahmen vs. Markt: TATACHEMDie Einnahmen des Unternehmens (7.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Indian (10.5% pro Jahr).
Hohe Wachstumseinnahmen: TATACHEMDie Einnahmen des Unternehmens (7.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: TATACHEMDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (5%).